The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML | PLOS ONE
Life | Free Full-Text | The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms
Highly Multiplexed Cell Surface Immunophenotyping with Genotyping and Concurrent Transcriptomic Analysis of NPM1 mutated Acute Myeloid Leukemia - ScienceDirect
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias | Haematologica
Anti-Nucleophosmin Monoclonal Antibody(Clone: NPM1/3398)
IJMS | Free Full-Text | Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia
Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity | Leukemia
Self-interaction of NPM1 modulates multiple mechanisms of liquid–liquid phase separation | Nature Communications
Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia | Science
Anti-Nucleophosmin Monoclonal Antibody(Clone: NPM1/3286)
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications | Leukemia
![Anti-Nucleophosmin Antibody [NPM1/3286] (A249528) | Antibodies.com](https://cdn.antibodies.com/image/catalog/249/A249528_3.jpg?profile=product_top "Anti-Nucleophosmin Antibody [NPM1/3286] (A249528) | Antibodies.com")
Anti-Nucleophosmin Antibody [NPM1/3286] (A249528) | Antibodies.com
Anti-Nucleophosmin Monoclonal Antibody(Clone: NPM1/3285)
NPM1 - Biocare Medical
Biological and clinical consequences of NPM1 mutations in AML | Leukemia
Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia - Yingyu Chen, Jianda Hu, 2020
Genes | Free Full-Text | Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
The potential role of nucleophosmin (NPM1) in the development of cancer - Karimi Dermani - 2021 - Journal of Cellular Physiology - Wiley Online Library
Assessment of Minimal Residual Disease in Standard-Risk AML | NEJM
![PDF] Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/374f1ff4b491f683ee5f662ae3309002122c3cbe/4-Table3-1.png "PDF] Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker | Semantic Scholar")
PDF] Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker | Semantic Scholar
Frontiers | Targeted therapy in NPM1-mutated AML: Knowns and unknowns
NPM1 re-distribution serves as a marker for nucleolar stress in glioma... | Download Scientific Diagram
